Bosung Park , Eunsang Suh , Yeseul Choi , Tae Yeul Kim , Eun Jeong Won , Hee Jae Huh , Heungsup Sung , Mi-Na Kim
{"title":"韩国非hiv患者隐球菌病的微生物学和临床流行病学:4年收集","authors":"Bosung Park , Eunsang Suh , Yeseul Choi , Tae Yeul Kim , Eun Jeong Won , Hee Jae Huh , Heungsup Sung , Mi-Na Kim","doi":"10.1016/j.jiph.2025.102842","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Cryptococcosis causes a high burden of disease worldwide; however, it has been relatively rare in Korea, where data on its prevalence and clinical characteristics remain limited. This study aimed to characterize the microbiological features of clinical cryptococcal isolates and to investigate the clinical profiles of HIV-negative patients with cryptococcosis in South Korea.</div></div><div><h3>Methods</h3><div>Clinical isolates of <em>Cryptococcus</em> species were collected from two university hospitals in South Korea (about 5000 beds, in total) over a 4-year period. Species identification, multilocus sequence typing, and antifungal susceptibility testing were performed. Clinical features of cryptococcosis and prognostic factors for 30-day mortality were analyzed by univariate and multivariate logistic regression analysis.</div></div><div><h3>Results</h3><div>A total of 40 nonduplicate isolates from 39 patients during the study period and sequencing confirmed 38 isolates of <em>C. neoformans</em> and 2 isolates of <em>C. deuterogatii</em>. MLST analysis of <em>C. neoformans</em> identified 35 isolates as ST5, along with single isolates of ST2, ST15, and a newly discovered sequence type, ST707. The percentages of non-wild type to amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, voriconazole, and posaconazole were 10.0 %, 4.0 %, 8.0 %, 6.0 %, 2.0 %, and 8.0 %, respectively. However, the two isolates of <em>C. deuterogatii</em> exhibited a wild type phenotype for all the aforementioned antifungal agents. Overall, the cumulative 30-day mortality rate was 41.0 % (16/39). Univariate analysis showed that total parenteral nutrition, severe sepsis, intensive care unit admission, vasopressor use, acute renal failure, and underlying chronic kidney disease (CKD) were risk factors for 30-day mortality, and azole therapy was the protective factor. Finally, CKD was the independent risk factor for 30-day mortality by multivariate analysis. No significant differences were observed in patient survival across sequence type of isolates.</div></div><div><h3>Conclusions</h3><div>This study showed that ST5 was the predominant genotype of <em>C. neoformans</em> in South Korea and CKD significantly increased the risk of 30-day mortality of cryptococcosis.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 9","pages":"Article 102842"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microbiological and clinical epidemiology of cryptococcosis in non-HIV Korean patients: 4-year collection\",\"authors\":\"Bosung Park , Eunsang Suh , Yeseul Choi , Tae Yeul Kim , Eun Jeong Won , Hee Jae Huh , Heungsup Sung , Mi-Na Kim\",\"doi\":\"10.1016/j.jiph.2025.102842\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Cryptococcosis causes a high burden of disease worldwide; however, it has been relatively rare in Korea, where data on its prevalence and clinical characteristics remain limited. This study aimed to characterize the microbiological features of clinical cryptococcal isolates and to investigate the clinical profiles of HIV-negative patients with cryptococcosis in South Korea.</div></div><div><h3>Methods</h3><div>Clinical isolates of <em>Cryptococcus</em> species were collected from two university hospitals in South Korea (about 5000 beds, in total) over a 4-year period. Species identification, multilocus sequence typing, and antifungal susceptibility testing were performed. Clinical features of cryptococcosis and prognostic factors for 30-day mortality were analyzed by univariate and multivariate logistic regression analysis.</div></div><div><h3>Results</h3><div>A total of 40 nonduplicate isolates from 39 patients during the study period and sequencing confirmed 38 isolates of <em>C. neoformans</em> and 2 isolates of <em>C. deuterogatii</em>. MLST analysis of <em>C. neoformans</em> identified 35 isolates as ST5, along with single isolates of ST2, ST15, and a newly discovered sequence type, ST707. The percentages of non-wild type to amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, voriconazole, and posaconazole were 10.0 %, 4.0 %, 8.0 %, 6.0 %, 2.0 %, and 8.0 %, respectively. However, the two isolates of <em>C. deuterogatii</em> exhibited a wild type phenotype for all the aforementioned antifungal agents. Overall, the cumulative 30-day mortality rate was 41.0 % (16/39). Univariate analysis showed that total parenteral nutrition, severe sepsis, intensive care unit admission, vasopressor use, acute renal failure, and underlying chronic kidney disease (CKD) were risk factors for 30-day mortality, and azole therapy was the protective factor. Finally, CKD was the independent risk factor for 30-day mortality by multivariate analysis. No significant differences were observed in patient survival across sequence type of isolates.</div></div><div><h3>Conclusions</h3><div>This study showed that ST5 was the predominant genotype of <em>C. neoformans</em> in South Korea and CKD significantly increased the risk of 30-day mortality of cryptococcosis.</div></div>\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"18 9\",\"pages\":\"Article 102842\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034125001911\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125001911","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Microbiological and clinical epidemiology of cryptococcosis in non-HIV Korean patients: 4-year collection
Background
Cryptococcosis causes a high burden of disease worldwide; however, it has been relatively rare in Korea, where data on its prevalence and clinical characteristics remain limited. This study aimed to characterize the microbiological features of clinical cryptococcal isolates and to investigate the clinical profiles of HIV-negative patients with cryptococcosis in South Korea.
Methods
Clinical isolates of Cryptococcus species were collected from two university hospitals in South Korea (about 5000 beds, in total) over a 4-year period. Species identification, multilocus sequence typing, and antifungal susceptibility testing were performed. Clinical features of cryptococcosis and prognostic factors for 30-day mortality were analyzed by univariate and multivariate logistic regression analysis.
Results
A total of 40 nonduplicate isolates from 39 patients during the study period and sequencing confirmed 38 isolates of C. neoformans and 2 isolates of C. deuterogatii. MLST analysis of C. neoformans identified 35 isolates as ST5, along with single isolates of ST2, ST15, and a newly discovered sequence type, ST707. The percentages of non-wild type to amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, voriconazole, and posaconazole were 10.0 %, 4.0 %, 8.0 %, 6.0 %, 2.0 %, and 8.0 %, respectively. However, the two isolates of C. deuterogatii exhibited a wild type phenotype for all the aforementioned antifungal agents. Overall, the cumulative 30-day mortality rate was 41.0 % (16/39). Univariate analysis showed that total parenteral nutrition, severe sepsis, intensive care unit admission, vasopressor use, acute renal failure, and underlying chronic kidney disease (CKD) were risk factors for 30-day mortality, and azole therapy was the protective factor. Finally, CKD was the independent risk factor for 30-day mortality by multivariate analysis. No significant differences were observed in patient survival across sequence type of isolates.
Conclusions
This study showed that ST5 was the predominant genotype of C. neoformans in South Korea and CKD significantly increased the risk of 30-day mortality of cryptococcosis.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.